Skip to main content
OpenTrials

Clinical trial condition

Proteostasis Deficiencies

Explore clinical trials studying Proteostasis Deficiencies. Study availability and eligibility vary by location and protocol.

1,350 public trials 353 recruiting studies
Refine in advanced search Browse all conditions

Proteostasis Deficiencies trial results

Active, Not Recruiting

Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology

NCT05184569

Conditions
Brain Diseases, Central Nervous System Diseases, Dementia, +11 more
Locations
  • UCSF Memory and Aging Center San Francisco, California, United States
  • Northwestern University Chicago, Illinois, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis

NCT05250973

Conditions
Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations
  • City of Hope Duarte, California, United States
  • Yale New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute Emory University Atlanta, Georgia, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)

NCT04504825

Conditions
AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +13 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Weston, Florida, United States
View all 90 locations
View Trial Details
Active, Not Recruiting

Neurofilament Surveillance Project (NSP)

NCT04516499

Conditions
Brain Diseases, Central Nervous System Diseases, Dementia, +14 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Johns Hopkins University School of Medicine Baltimore, Maryland, United States
  • Massachusetts General Hospital Charlestown, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)

NCT04512235

Conditions
AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +13 more
Locations
  • Research Site Scottsdale, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site San Francisco, California, United States
View all 110 locations
View Trial Details
Active, Not Recruiting

TRIAL READY (Clinical Trial Readiness)

NCT03912987

Conditions
ALS-Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, Brain Diseases, +18 more
Locations
  • University of Miami Miami, Florida, United States
  • University of Kansas Kansas City, Kansas, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Phenotype, Genotype and Biomarkers 2

NCT04875416

Conditions
Amyotrophic Lateral Sclerosis, Brain Diseases, Central Nervous System Diseases, +27 more
Locations
  • University of Miami Miami, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Cape Town Cape Town, South Africa
View Trial Details

Related conditions